166 related articles for article (PubMed ID: 34331768)
1. Reduced infiltration of regulatory T cells in tumours from mice fed daily with gamma-tocotrienol supplementation.
Subramaniam S; Anandha Rao JS; Ramdas P; Ng MH; Kannan Kutty M; Selvaduray KR; Radhakrishnan AK
Clin Exp Immunol; 2021 Nov; 206(2):161-172. PubMed ID: 34331768
[TBL] [Abstract][Full Text] [Related]
2. Gamma-tocotrienol modifies methylation of HOXA10, IRF4 and RORα genes in CD4
Radhakrishnan AK; Anandha Rao JS; Subramaniam S; Ramdas P
Curr Res Immunol; 2021; 2():169-174. PubMed ID: 35492388
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Anticancer and Immunomodulatory Effects of
Subramaiam H; Chu WL; Radhakrishnan AK; Chakravarthi S; Selvaduray KR; Kok YY
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371830
[TBL] [Abstract][Full Text] [Related]
4. Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment.
Han SJ; Sung N; Wang J; O'Malley BW; Lonard DM
Breast Cancer Res; 2022 Oct; 24(1):73. PubMed ID: 36316775
[TBL] [Abstract][Full Text] [Related]
5. Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells.
Manukian G; Kivolowitz C; DeAngelis T; Shastri AA; Savage JE; Camphausen K; Rodeck U; Zarif JC; Simone NL
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1341-1349. PubMed ID: 33647370
[TBL] [Abstract][Full Text] [Related]
6. α-Tocopheryloxyacetic acid: a novel chemotherapeutic that stimulates the antitumor immune response.
Hahn T; Jagadish B; Mash EA; Garrison K; Akporiaye ET
Breast Cancer Res; 2011 Jan; 13(1):R4. PubMed ID: 21232138
[TBL] [Abstract][Full Text] [Related]
7. Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.
Taylor NA; Vick SC; Iglesia MD; Brickey WJ; Midkiff BR; McKinnon KP; Reisdorf S; Anders CK; Carey LA; Parker JS; Perou CM; Vincent BG; Serody JS
J Clin Invest; 2017 Sep; 127(9):3472-3483. PubMed ID: 28825599
[TBL] [Abstract][Full Text] [Related]
8. Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions.
Maulhardt H; Marin A; Hesseltine H; diZerega G
Med Oncol; 2021 Jul; 38(9):106. PubMed ID: 34331595
[TBL] [Abstract][Full Text] [Related]
9. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
Jarnicki AG; Lysaght J; Todryk S; Mills KH
J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of anti-cancer and immunomodulatory effects of carnosol in a Balb/c WEHI-164 fibrosarcoma model.
Rahnama M; Mahmoudi M; Zamani Taghizadeh Rabe S; Balali-Mood M; Karimi G; Tabasi N; Riahi-Zanjani B
J Immunotoxicol; 2015; 12(3):231-8. PubMed ID: 25027673
[TBL] [Abstract][Full Text] [Related]
11. Promoted Generation of T Helper 1-Like Regulatory T Cells After Transient Middle Cerebral Artery Occlusion in Type-2 Diabetic Mice.
Jian L; Hu Y; Gao M; Shu L
Immunol Invest; 2023 Nov; 52(4):482-498. PubMed ID: 37076315
[TBL] [Abstract][Full Text] [Related]
12. Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathway.
Su L; Jiang Y; Xu Y; Li X; Gao W; Xu C; Zeng C; Song J; Weng W; Liang W
Biomed Pharmacother; 2018 Jun; 102():1111-1119. PubMed ID: 29710529
[TBL] [Abstract][Full Text] [Related]
13. B7-H4 overexpression impairs the immune response of T cells in human cervical carcinomas.
Wang X; Wang T; Xu M; Xiao L; Luo Y; Huang W; Zhang Y; Geng W
Hum Immunol; 2014 Dec; 75(12):1203-9. PubMed ID: 25446402
[TBL] [Abstract][Full Text] [Related]
14. Artemisinin enhances the anti-tumor immune response in 4T1 breast cancer cells in vitro and in vivo.
Cao Y; Feng YH; Gao LW; Li XY; Jin QX; Wang YY; Xu YY; Jin F; Lu SL; Wei MJ
Int Immunopharmacol; 2019 May; 70():110-116. PubMed ID: 30798159
[TBL] [Abstract][Full Text] [Related]
15. Recombinant virus-like particles presenting IL-33 successfully modify the tumor microenvironment and facilitate antitumor immunity in a model of breast cancer.
Feng X; Liu H; Chu X; Sun P; Huang W; Liu C; Yang X; Sun W; Bai H; Ma Y
Acta Biomater; 2019 Dec; 100():316-325. PubMed ID: 31542504
[TBL] [Abstract][Full Text] [Related]
16. Heterodimeric IL-15 delays tumor growth and promotes intratumoral CTL and dendritic cell accumulation by a cytokine network involving XCL1, IFN-γ, CXCL9 and CXCL10.
Bergamaschi C; Pandit H; Nagy BA; Stellas D; Jensen SM; Bear J; Cam M; Valentin A; Fox BA; Felber BK; Pavlakis GN
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32461349
[TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells prevent CD8 T cell maturation by inhibiting CD4 Th cells at tumor sites.
Chaput N; Darrasse-Jèze G; Bergot AS; Cordier C; Ngo-Abdalla S; Klatzmann D; Azogui O
J Immunol; 2007 Oct; 179(8):4969-78. PubMed ID: 17911581
[TBL] [Abstract][Full Text] [Related]
18. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
19. Identification of CD8+CD25+Foxp3+ suppressive T cells in colorectal cancer tissue.
Chaput N; Louafi S; Bardier A; Charlotte F; Vaillant JC; Ménégaux F; Rosenzwajg M; Lemoine F; Klatzmann D; Taieb J
Gut; 2009 Apr; 58(4):520-9. PubMed ID: 19022917
[TBL] [Abstract][Full Text] [Related]
20. The heterogeneous immune microenvironment in breast cancer is affected by hypoxia-related genes.
Duechler M; Peczek L; Zuk K; Zalesna I; Jeziorski A; Czyz M
Immunobiology; 2014 Feb; 219(2):158-65. PubMed ID: 24091277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
